Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on April 29, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Clinical Trials Program National Institute on Deafness and Other Communication Disorders (NIDCD)

Closed
75N98024R00012Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

SBA

Documents

11

Amendment 002 to RFP 75N98024R00012 (NIDCD)

PDF, High priority: read this first84 pages · amendment
High

Amendment 003 to RFP 75N98024R00012 (NIDCD)

PDF, High priority: read this first83 pages · amendment
High

Amendment 004 to RFP 75N98024R00012 (NIDCD)

PDF, High priority: read this first83 pages · amendment
High

FAR 52.212-3 Offeror Representations and Certifications

PDF, High priority: read this first25 pages · reps-and-certs
High

NIDCD Clinical Trials Program Coordination and Operations RFP 75N98024R00012

PDF, High priority: read this firstrfp
High

NIDCD Clinical Trials Program RFP# 75N98024R00012 Q&A Document

PDF, High priority: read this first24 pages · q-and-a
High

Pricing Table - Clinical Trials Coordination and Operational Support (75N98024R00012)

XLS, High priority: read this first4 pages · specifications
High

RFP 75N98024R00012 - NIDCD

PDF, High priority: read this first83 pages · rfp
High

NIDCD Extramural Clinical Trials Coordination & Operations Pre-Proposal Conference Slides

ZIP, Low priority7 pages · industry-day
Low

Past Performance Questionnaire

PDF, Low priority4 pages · past-performance
Low

Proposal Intent Response Form - RFP 75N98024R00012

PDF, Low priorityintent-to-bid
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

6 updates
PhaseClosed
Posted

Solicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

Response deadline changed from Apr 30, 2024 to May 15, 2024. The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more
THE FOLLOWING UPDATES HAVE BEEN MADE (4/29/2024) RFP Amendment 004 attached Questions and Response Document attached Reps and Certs - Commercial FAR 52.212-3 Document attached Pre-Proposal Conference Slides attached RFP Amendment 004 attached; page 20-21 section H.8. removed; see highlighed RFP Amendment 004 attached; page 47-48, section List of Attachments, see highlighted RFP Amendment 004 attached; page 60-61, section Instructions to Offerors RFP Amendment 004 attached; page 71; section Business Proposal; see highlighted RFP Amendment 004 attached; page 73-75 section Small Business Subcontracting Plan removed, see highlighted RFP Amendment 004 attached; page 80; section M General, see highlighted RFP Amendment 004 attached; page 81; section Mandatory Qualification Criteria; see highlighted RFP Amendment 004 attached; page 82-83; section Cost Price Evaluation; see highlighted ________________________________________________________________________ THE FOLLOWING UPDATES HAVE BEEN MADE (4/23/2024) RFP Amendment 003 attached; changes highlighted in yellow, section J List of Attachments Attachment 5 reworded from Reference Response Form to Reference Response Attached Past Performance Questionnaire. The afformentioned document is an electronic file attached to this RFP entiltled: 'Past Performance Questionnaire' RFP Amendment 003 attached; changes highlighted in yellow; section Techncial Proposal Instructions page 67-68 added. Pricing Table added as an electonic file to this RFP; entitled: 'Pricing Table' ______________________________________________________________________________ THE FOLLOWING UPDATES HAVE BEEN MADE (4/12/2024) RFP Amendment 002 attached; changes highlighted in yellow, section Techncial Discussion page 67-68 Technical Evaluation Criteria revised. RFP Amendment 002 attached; changes highlighted in yellow; section Business Proposal Instructions number 10 page 77-78 removed. ______________________________________________________________________________ THE FOLLOWING UPDATES HAVE BEEN MADE (4/3/2024) A Pre-Proposal Conference will be held virtually on Monday, April 8, 2024 from 10:00am-12:00pm EST. Registration is required to attend this event. Please use the following link to register: https://www.eventbrite.com/e/nih-olao-nidcd-clinical-trials-program-pre-proposal-conference-tickets-862980436717?utm-campaign=social&utm-content=attendeeshare&utm-medium=discovery&utm-term=listing&utm-source=cp&aff=ebdsshcopyurl Vendors attending the pre-proposal conference are expected to fully read and understand the RFP prior to the event. There is a maximum number of 500 attendees. If you have specific questions regarding this requirement please send your questions to NIHSmallBusiness@mail.nih.gov by COB April 5, 2024. Registrants will receive the link to access this event on April 6, 2024 by COB. _______________________________________________________________________________________________ THE FOLLOWING UPDATES HAVE BEEN MADE (4/2/2024) Proposal Intent Response Form added as attachment Past Performance Questionnaire Form added as attachement _______________________________________________________________________________________________ THE FOLLOWING UPDATES HAVE BEEN MADE Please note that the Pre-Proposal Conference has been rescheulded to Monday, April 8, 2024. A SAM notice will be publised with additional detals. RFP Page 1: Proposal Response Date is 05/15/2024 (Revised RFP attached see highlighted) RFP Page 61: Questions shall be submitted by 04/15/2024; Notice of Intent shall be submitted 05/01/2024; Proposals shall be submitted 05/15/2024 (Revised RFP attached see highlighted) ________________________________________________________________________________________ The National Institute of Health (NIH) intends to award a service contract to support the National Institutes on Deafness and Other Communication Disorders (NIDCD) Clinical Trials Program (CTP) coordination and operations. The NIDCD cooperative agreement high risk clinical trials continue to expand in number, complexity of scope, risks, and external collaborations e.g., multi-site, intra- and inter-agency. NIDCD needs coordinating and operational services by specialized individuals who have knowledge and expertise in industry standard clinical trial protocol development, readiness for implementation, project management, operations, monitoring, quality management, and data management. The purpose of this contract is to directly work with research teams to provide project management as well as improve clinical trial implementation readiness, quality management and clinical data quality management for NIDCD-funded high risk clinical trials. See Attached Request for Proposal (RFP)

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 325411
New
Federal
NOI - B2B Award entitled - Developing Red Cell-Sp
Solicitation # 75N98027Q00017
Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in 14 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS